title: Relapsing peritonitis with Corynebacterium aquaticum in a boy receiving automated peritoneal dialysis.
authors.forename: Shuichiro
authors.initials: S
authors.lastname: Fujinaga
authors.forename: Yoshiyuki
authors.initials: Y
authors.lastname: Ohtomo
authors.forename: Daishi
authors.initials: D
authors.lastname: Hirano
authors.forename: Naoto
authors.initials: N
authors.lastname: Nishizaki
authors.forename: Tomonosuke
authors.initials: T
authors.lastname: Someya
authors.forename: Yoshikazu
authors.initials: Y
authors.lastname: Ohtsuka
authors.forename: Kazunari
authors.initials: K
authors.lastname: Kaneko
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Shimizu
mesh_terms: D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002437:Cefazolin / Q000627:therapeutic use; D002442:Ceftazidime / Q000627:therapeutic use; D003352:Corynebacterium / Q000187:drug effects / Q000302:isolation & purification*; D003354:Corynebacterium Infections / Q000188:drug therapy / Q000382:microbiology*; D004338:Drug Combinations; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy / Q000382:microbiology*; D012008:Recurrence; D016896:Treatment Outcome; D014640:Vancomycin / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D014640:Vancomycin; D002442:Ceftazidime; D002437:Cefazolin